Sign In
Buy SPPI
$1.03
+0 (+0%)
At Close: Oct 30, 2023
New Strong Buy Stocks for July 13th
11:00am, Wednesday, 13'th Jul 2022 Zacks Investment Research
KMI, UFCS, GKOS, SPPI and BECN have been added to the Zacks Rank #1 (Strong Buy) List on July 13, 2022.
New Strong Buy Stocks for July 13th
08:29am, Wednesday, 13'th Jul 2022
KMI, UFCS, GKOS, SPPI and BECN have been added to the Zacks Rank #1 (Strong Buy) List on July 13, 2022.
Corcept (CORT) Thrives on Korlym Amid Overdependence Concerns
03:14pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Corcept's (CORT) Cushing's syndrome drug, Korlym, is making good progress. Other pipeline candidates are advancing as well. However, heavy dependence on Korlym for growth remains an overhang.
Hot Penny Stocks Under $1 To Watch In June
07:56pm, Thursday, 02'nd Jun 2022 PennyStocks
Penny stocks to watch under $1 right now
The post Hot Penny Stocks Under $1 To Watch In June appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
07:00am, Thursday, 02'nd Jun 2022
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will particip
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced additional exploratory data f
Spectrum Pharmaceuticals (SPPI) Q1 2022 Earnings Call Transcript
04:00am, Friday, 13'th May 2022 The Motley Fool
SPPI earnings call for the period ending March 31, 2022.
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Thomas Riga on Q1 2022 Results - Earnings Call Transcript
07:20pm, Thursday, 12'th May 2022
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ) Q1 2022 Results Conference Call May 12, 2022 4:30 PM ET Company Participants Michael Grabow - Senior Vice President of Corporate Strategy and Operations T
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
12:42pm, Thursday, 12'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology
BridgeBio Pharma Inc
HC Wainwright Sees Almost 1000% Upside On Spectrum Pharma Stock
06:05pm, Friday, 18'th Mar 2022 Benzinga
HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ: SPPI), with a price target of $10.
The analyst projects revenues of $170 million for Rolontis and $328 million for
HC Wainwright Sees Almost 1000% Upside On Spectrum Pharma Stock
02:08pm, Friday, 18'th Mar 2022
HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ: SPPI), with a price target of $10. The analyst projects revenues of $170 million for Rolontis and $328 million for
Spectrum Pharmaceuticals (SPPI) Q4 2021 Earnings Call Transcript
01:30am, Friday, 18'th Mar 2022 The Motley Fool
SPPI earnings call for the period ending December 31, 2021.
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Tom Riga on Q4 2021 Results - Earnings Call Transcript
09:11pm, Thursday, 17'th Mar 2022
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Tom Riga on Q4 2021 Results - Earnings Call Transcript
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
11:53am, Thursday, 17'th Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
AbbVie's Rinvoq Gets Label Expansion To Treat Ulcerative Colitis
AbbVie, Inc. (NYSE: ABBV) announced
Spectrum Pharmaceuticals Q4 2021 Earnings Preview (NASDAQ:SPPI)
09:35pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Spectrum Pharmaceuticals (NASDAQ:SPPI) is scheduled to announce Q4 earnings results on Wednesday, March 16th, after market close.The consensus EPS Estimate is -$0.18 (+10.0% Y/Y) and…
